Anacetrapib as lipid-modifying therapy in patients with heterozygous familial hypercholesterolaemia (REALIZE): a randomised, double-blind, placebo-controlled, phase 3 study
Kastelein, John J P, Prof, Besseling, Joost, MD, Shah, Sukrut, PhD, Bergeron, Jean, MD, Langslet, Gisle, MD, Hovingh, G Kees, MD, Al-Saady, Naab, MD, Koeijvoets, Michiel, BSc, Hunter, John, MS, Johnson-Levonas, Amy O, PhD, Fable, Jennifer, PharmD, Sapre, Aditi, PhD, Mitchel, Yale, MD
Published in The Lancet (British edition) (30.05.2015)
Published in The Lancet (British edition) (30.05.2015)
Get full text
Journal Article
Lipid-modifying Efficacy and Tolerability of Anacetrapib Added to Ongoing Statin Therapy in Patients With Hypercholesterolemia or Low High-density Lipoprotein Cholesterol
Ballantyne, Christie M., MD, Shah, Sukrut, PhD, Kher, Uma, MS, Hunter, John A., MS, Gill, Geraldine G., MPharm, Cressman, Michael D., DO, Ashraf, Tanya B., BA, Johnson-Levonas, Amy O., PhD, Mitchel, Yale B., MD
Published in The American journal of cardiology (01.02.2017)
Published in The American journal of cardiology (01.02.2017)
Get full text
Journal Article
Converting to doxercalciferol capsules from intravenous paricalcitol or doxercalciferol
Kant, K Shashi, Gonzalez, Alejandro R, Hariachar, Srinivas, Bernardo, Marializa, Duggal, Ajay, Engstrand, Sara, Hunter, John, Plone, Melissa, Hertel, Joachim
Published in Journal of renal nutrition (01.01.2012)
Published in Journal of renal nutrition (01.01.2012)
Get more information
Journal Article